Annora Pharma Private Limited recalls
2 notices naming Annora Pharma Private Limited as the recalling firm, since March 25, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Annora Pharma Private Limited: Lacosamide Tablets
Hazard (FDA): Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
FDAMedicines
Annora Pharma Private Limited: Pitavastatin Tablets
Hazard (FDA): Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
FDAMedicines